&nbsp;

SerousOvarianCancerTreatmentPathwayMap.pdf

Apr 2025

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

May 2025

Drug

niraparib / abiraterone

Other Name(s): Akeega™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Sep 2025

Document

Support-on-Your-Palliative-Care-Journey.pdf

Jun 2025

Document

Support-on-Your-Palliative-Care-Journey-thumbnail.jpg

Jun 2025

Document

Spring2025ProvincialColposcopyCoPWebinarSlides.pdf

Jul 2025

Guidelines and Advice

Systemic Treatment Emergency Preparedness Guidance Document

Status: Current

Updated

Aug 2025

Regimen

NIVL+IPIL

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Drugs Used:

nivolumab (Compassionate),

ipilimumab (Compassionate)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

NIVL+IPIL

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - MSI-H/dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer

New Drug Funding Program

Nivolumab plus Ipilimumab - MSI-H/dMMR Locally Advanced Unresectable or Metastatic Colorectal Cancer

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

Dec 2025

Regimen

NIVL(MNT)

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Drugs Used:

nivolumab (Unfunded)